Alzheimer’s is one of the greatest public health challenges of our time, affecting more than seven million Americans, including nearly 29,000 people in Maine. Early diagnosis is essential, yet too many patients continue to go undiagnosed until their symptoms become severe. That is why, today, I introduced bipartisan legislation that would require the Centers for Medicare & Medicaid Services (CMS) to create a pathway to cover blood biomarker tests approved by the FDA for the early detection of Al